Karen MacDonald Selected Research

Filgrastim (Neupogen)

1/2020	Febrile neutropenia hospitalization due to pegfilgrastim on-body injector failure compared to single-injection pegfilgrastim and daily injections with reference and biosimilar filgrastim: US cost simulation for lung cancer and non-Hodgkin lymphoma.
6/2019	Outcomes of chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim (Zarzio®) initiated "same-day" (< 24 h), "per-guidelines" (24-72 h), and "late" (> 72 h): findings from the MONITOR-GCSF study.
3/2019	Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF study.
1/2018	Reply: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
10/2017	Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia.
10/2017	Expanded access to cancer treatments from conversion to neutropenia prophylaxis with biosimilar filgrastim-sndz.
1/2017	Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study.
1/2017	Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study).
2/2016	Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).
1/2016	Erratum to: Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karen MacDonald Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 01/2008
12	Chemotherapy-Induced Febrile Neutropenia 01/2021 - 03/2011
7	Febrile Neutropenia 11/2021 - 03/2011
6	Anemia 11/2021 - 01/2008
5	Neutropenia 11/2021 - 01/2017
5	Hypertension (High Blood Pressure) 01/2021 - 05/2009
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 06/2011
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 05/2009
2	Asthma (Bronchial Asthma) 01/2021 - 09/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2011
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 06/2019 - 12/2016
2	Urticaria (Hives) 01/2019 - 01/2018
1	Gallstones (Gallstone) 01/2022
1	COVID-19 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021
1	Thrombocytopenia (Thrombopenia) 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Nausea 03/2020
1	Vomiting 03/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Macular Edema 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 03/2019
1	Chronic Urticaria 01/2019
1	Weight Gain 01/2019
1	Pure Red-Cell Aplasia 01/2018
1	Sarcoidosis (Schaumann Disease) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2012
1	Iron Overload 06/2011
1	Multiple Myeloma 03/2011
1	Ovarian Neoplasms (Ovarian Cancer) 03/2011
1	Alzheimer Disease (Alzheimer's Disease) 10/2007

Drug/Important Bio-Agent (IBA)

22	Biosimilar PharmaceuticalsIBA 01/2022 - 03/2011
13	Filgrastim (Neupogen)FDA Link 01/2020 - 03/2011
9	pegfilgrastim (Neulasta)FDA Link 01/2022 - 10/2017
4	Valsartan (Vals)FDA Link 01/2021 - 05/2009
4	Omalizumab (Xolair)FDA Link 01/2021 - 09/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2020
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
3	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2017
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2017 - 03/2011
3	IronIBA 01/2017 - 06/2011
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 05/2009
2	Rituximab (Mabthera)FDA Link 01/2021 - 04/2015
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2017
2	VildagliptinIBA 06/2019 - 12/2016
2	Metformin (Glucophage)FDA LinkGeneric 06/2019 - 12/2016
2	Epoetin Alfa (Epogen)FDA Link 01/2018 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 04/2015 - 01/2014
2	HematinicsIBA 04/2013 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 07/2010 - 01/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	SolutionsIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	trilaciclibIBA 11/2021
1	folfirinoxIBA 11/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021
1	pertuzumabIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	pembrolizumabIBA 08/2020
1	Pharmaceutical PreparationsIBA 08/2020
1	Neurokinin-1 Receptor AntagonistsIBA 03/2020
1	Olanzapine (Zyprexa)FDA Link 03/2020
1	Palonosetron (Aloxi)FDA Link 03/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2020
1	Thalidomide (Thalomid)FDA Link 03/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2019
1	Glucose (Dextrose)FDA LinkGeneric 06/2019
1	AlbuminsIBA 01/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	AntibodiesIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017
1	Hemoglobins (Hemoglobin)IBA 04/2013
1	Valsartan Drug Combination Amlodipine FDA Link 06/2011
1	Rivastigmine (Exelon)FDA LinkGeneric 10/2007
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2007

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 11/2021 - 01/2008
11	Therapeutics 11/2021 - 10/2007
2	Chelation Therapy (Therapy, Chelation) 05/2014 - 06/2011
1	Laparoscopic Cholecystectomy 01/2022
1	Injections 01/2020
1	Renal Dialysis (Hemodialysis) 01/2018
1	Antibiotic Prophylaxis 01/2017
1	Cardiac Rehabilitation 01/2015
1	Aftercare (After-Treatment) 07/2010